{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T16:42:16Z","timestamp":1648917736360},"reference-count":20,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"published-print":{"date-parts":[[2015,3]]},"abstract":"<jats:p>Background Alcoholic liver disease is a major cause of end-stage liver disease worldwide and severe forms of alcoholic hepatitis are associated with a high short-term mortality. Objectives To analyze the importance of age-bilirubin-INR-creatinine (ABIC) score as an index of mortality and predictor for complications in patients with alcoholic hepatitis. To evaluate its correlation with those complications, with risk of death, as well as the scores model for end stage liver disease (MELD) and Maddrey\u2019s discriminat function. Methods A total of 46 medical records of patients who had been hospitalized with alcoholic hepatitis were assessed retrospectively with lab tests on admission and after seven days. Score calculations were carried out and analyzed as well. Results The scores showed positive reciprocal correlation and were associated with both hepatic encephalopathy and ascites. ABIC index, which was classified as high risk, presented as a risk factor for these complications and for death. In univariate logistic regression analysis of mortality, the ABIC index at hospital admission odds ratio was 19.27, whereas after 7 days, it was 41.29. The average survival of patients with ABIC of low and intermediate risk was 61.1 days, and for those with high risk, 26.2 days. Conclusions ABIC index is a predictor factor for complications such as ascites and hepatic encephalopathy, as well as for risk of death. Thus, it is a useful tool for clinical practice.<\/jats:p>","DOI":"10.1590\/s0004-28032015000100006","type":"journal-article","created":{"date-parts":[[2015,5,17]],"date-time":"2015-05-17T00:23:12Z","timestamp":1431822192000},"page":"22-26","source":"Crossref","is-referenced-by-count":1,"title":["USEFULNESS OF A NEW PROGNOSTIC INDEX FOR ALCOHOLIC HEPATITIS"],"prefix":"10.1590","volume":"52","author":[{"given":"Jazon Romilson de Souza","family":"ALMEIDA","sequence":"first","affiliation":[{"name":"Universidade de Campinas, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta Chaves","family":"ARA\u00daJO","sequence":"additional","affiliation":[{"name":"Universidade de Campinas, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giane Vieira de","family":"CASTILHO","sequence":"additional","affiliation":[{"name":"Universidade de Campinas, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia","family":"STAHELIN","sequence":"additional","affiliation":[{"name":"Universidade de Campinas, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia dos Reis","family":"PANDOLFI","sequence":"additional","affiliation":[{"name":"Universidade de Campinas, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cec\u00edlia Queiroz","family":"SILVA","sequence":"additional","affiliation":[{"name":"Universidade de Campinas, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebocontrolled trial","volume":"19","author":"Akriviadis E","year":"2000","journal-title":"Gastroenterology"},{"issue":"12","key":"ref2","first-page":"644","article-title":"Asymptomatic liver disease in alcoholics","volume":"101","author":"Bruguera M","year":"1997","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers RL","year":"1989","journal-title":"Ann Intern Med"},{"issue":"20","key":"ref4","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.3748\/wjg.v20.i20.6279","article-title":"Alcoholic hepatits: a comprehensive review of pathogenesis and treatment","volume":"20","author":"Chayanupatkul M","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A new scoring for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez M","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref6","first-page":"304","article-title":"\"Drinking behaviour between alcohol users: a followup study\"","volume":"33","author":"Fontes A","year":"2006","journal-title":"Rev Psiq Cl\u00edn"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao B","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1152\/ajpgi.00094.2004","article-title":"Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis","volume":"287","author":"Hines IN","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1530-0277.1991.tb00518.x","article-title":"Alcoholic liver disease: pathologic, pathogenetic and clinical aspects","volume":"15","author":"Ishak KG","year":"1991","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"The clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study","volume":"51","author":"Jepsen P","year":"2010","journal-title":"Hepatol"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath PS","year":"2001","journal-title":"Hepatology"},{"issue":"2","key":"ref12","first-page":"105","article-title":"Alcoholic liver disease: a public health issue in need of a public health approach","volume":"13","author":"Lieber CS","year":"1993","journal-title":"Semin Liver Dis"},{"issue":"26","key":"ref13","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey DM","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey WC","year":"1978","journal-title":"Gastroenterology"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severeAH","volume":"36","author":"Mathurin P","year":"2002","journal-title":"J of Hepatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0168-8278(12)60005-1","article-title":"Management of alcoholic hepatitis","volume":"56","author":"Mathurin P","year":"2012","journal-title":"J Hepatol"},{"key":"ref17","series-title":"Global status report on alcohol","year":"2011"},{"key":"ref18","first-page":"44","article-title":"Alcoholic liver disease - An update . Gastroenterology Research Unit, Mayo Clinic, Rochester","author":"Shah VH","year":"2009","journal-title":"US Gastroenterology & Hepatology Review"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.gtc.2011.06.008","article-title":"Alcoholic hepatitis: prognostic models and treatment","volume":"40","author":"Singal AK","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cld.2012.08.005","article-title":"Diagnosis and management of alcoholic hepatitis","volume":"16","author":"Sohail U","year":"2012","journal-title":"Clin Liver Dis"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v52n1\/0004-2803-ag-52-01-22.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T06:22:36Z","timestamp":1566714156000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032015000100006&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0004-28032015000100006"],"URL":"https:\/\/doi.org\/10.1590\/s0004-28032015000100006","relation":{},"ISSN":["0004-2803"],"issn-type":[{"value":"0004-2803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}